109 related articles for article (PubMed ID: 33660848)
1. Comparison of preoperative serum neopterin, periostin, indoleamine 2,3-dioxygenase, YKL-40, and tenascin-C levels with current tumor markers for early-stage endometrial cancer.
Unuvar S; Melekoglu R; Turkmen NB; Yilmaz E; Yasar S; Yuce H
Int J Gynaecol Obstet; 2021 Dec; 155(3):417-424. PubMed ID: 33660848
[TBL] [Abstract][Full Text] [Related]
2. The usefulness of biomarkers in diagnosis of asbestos-induced malignant pleural mesothelioma.
Tanrıverdi Z; Meteroglu F; Yüce H; Şenyiğit A; Işcan M; Unüvar S
Hum Exp Toxicol; 2021 Nov; 40(11):1817-1824. PubMed ID: 33998299
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of serum neopterin, periostin, Tenascin-C, tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-2 levels in obese pregnant women.
Melekoğlu R; Ünüvar S; Türkmen NB; Çetin A; Zeyveli Çelik N; Yüce H; Yaşar Ş
Turk J Obstet Gynecol; 2022 Dec; 19(4):257-267. PubMed ID: 36511564
[TBL] [Abstract][Full Text] [Related]
4. Relationship between indoleamine 2,3-dioxygenase activity and lymphatic invasion propensity of colorectal carcinoma.
Engin A; Gonul II; Engin AB; Karamercan A; Sepici Dincel A; Dursun A
World J Gastroenterol; 2016 Apr; 22(13):3592-601. PubMed ID: 27053851
[TBL] [Abstract][Full Text] [Related]
5. Neopterin Levels and Indoleamine 2,3-Dioxygenase Activity as Biomarkers of Immune System Activation and Childhood Allergic Diseases.
Ünüvar S; Erge D; Kılıçarslan B; Gözükara Bağ HG; Çatal F; Girgin G; Baydar T
Ann Lab Med; 2019 May; 39(3):284-290. PubMed ID: 30623620
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic values of preoperative serum levels of YKL-40, HE-4 and DKK-3 in endometrial cancer.
Kemik P; Saatli B; Yıldırım N; Kemik VD; Deveci B; Terek MC; Koçtürk S; Koyuncuoğlu M; Saygılı U
Gynecol Oncol; 2016 Jan; 140(1):64-9. PubMed ID: 26607777
[TBL] [Abstract][Full Text] [Related]
7. Association between endometrial indoleamine 2,3-dioxygenase expression level and pregnancy outcomes in women undergoing first in vitro fertilization treatment.
Liu S; Hong L; Li Y; Lian R; Wang X; Zeng Y
BMC Pregnancy Childbirth; 2021 Jan; 21(1):33. PubMed ID: 33413226
[TBL] [Abstract][Full Text] [Related]
8. Combined Assessment of Serum Periostin and YKL-40 May Identify Asthma-COPD Overlap.
Shirai T; Hirai K; Gon Y; Maruoka S; Mizumura K; Hikichi M; Holweg C; Itoh K; Inoue H; Hashimoto S
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):134-145.e1. PubMed ID: 29981861
[TBL] [Abstract][Full Text] [Related]
9. Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer.
Ino K; Yoshida N; Kajiyama H; Shibata K; Yamamoto E; Kidokoro K; Takahashi N; Terauchi M; Nawa A; Nomura S; Nagasaka T; Takikawa O; Kikkawa F
Br J Cancer; 2006 Dec; 95(11):1555-61. PubMed ID: 17117179
[TBL] [Abstract][Full Text] [Related]
10. Assessment of neopterin and indoleamine 2,3-dioxygenase activity in patients with seasonal influenza: A pilot study.
Pizzini A; Kurz K; Santifaller J; Tschurtschenthaler C; Theurl I; Fuchs D; Weiss G; Bellmann-Weiler R
Influenza Other Respir Viruses; 2019 Nov; 13(6):603-609. PubMed ID: 31489989
[TBL] [Abstract][Full Text] [Related]
11. Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer.
Diefenbach CS; Shah Z; Iasonos A; Barakat RR; Levine DA; Aghajanian C; Sabbatini P; Hensley ML; Konner J; Tew W; Spriggs D; Fleisher M; Thaler H; Dupont J
Gynecol Oncol; 2007 Feb; 104(2):435-42. PubMed ID: 17023034
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic value of serum YKL-40 in endometrial cancer: a meta-analysis.
Qin R; Liao M; Qin W; Wang J; Zheng F; Ma N; Zhao Y; Qin A
Biomarkers; 2022 May; 27(3):215-221. PubMed ID: 34974784
[TBL] [Abstract][Full Text] [Related]
13. Amino acid profile index for early detection of endometrial cancer: verification as a novel diagnostic marker.
Ihata Y; Miyagi E; Numazaki R; Muramatsu T; Imaizumi A; Yamamoto H; Yamakado M; Okamoto N; Hirahara F
Int J Clin Oncol; 2014 Apr; 19(2):364-72. PubMed ID: 23700142
[TBL] [Abstract][Full Text] [Related]
14. Serum tryptophan and kynurenine concentrations as parameters for indoleamine 2,3-dioxygenase activity in patients with endometrial, ovarian, and vulvar cancer.
de Jong RA; Nijman HW; Boezen HM; Volmer M; Ten Hoor KA; Krijnen J; van der Zee AG; Hollema H; Kema IP
Int J Gynecol Cancer; 2011 Oct; 21(7):1320-7. PubMed ID: 21720257
[TBL] [Abstract][Full Text] [Related]
15. Predictive and prognostic role of serum neopterin and tryptophan breakdown in prostate cancer.
Pichler R; Fritz J; Heidegger I; Steiner E; Culig Z; Klocker H; Fuchs D
Cancer Sci; 2017 Apr; 108(4):663-670. PubMed ID: 28107600
[TBL] [Abstract][Full Text] [Related]
16. Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer: its association with disease progression and survival.
Ino K; Yamamoto E; Shibata K; Kajiyama H; Yoshida N; Terauchi M; Nawa A; Nagasaka T; Takikawa O; Kikkawa F
Clin Cancer Res; 2008 Apr; 14(8):2310-7. PubMed ID: 18413819
[TBL] [Abstract][Full Text] [Related]
17. A New Diagnostic and Prognostic Marker in Endometrial Cancer: Neopterin.
Isci Bostanci E; Ugras Dikmen A; Girgin G; Gungor T; Baydar T; Nuri Danisman A
Int J Gynecol Cancer; 2017 May; 27(4):754-758. PubMed ID: 28383326
[TBL] [Abstract][Full Text] [Related]
18. Indoleamine 2,3 dioxygenase as a prognostic and follow-up marker in melanoma. A comparative study with LDH and S100B.
de Lecea MV; Palomares T; Al Kassam D; Cavia M; Geh JLC; de Llano P; Muñiz P; Armesto D; Martinez-Indart L; Alonso-Varona A
J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):636-642. PubMed ID: 27633490
[TBL] [Abstract][Full Text] [Related]
19. [Value of indoleamine 2,3-dioxygenase in diagnosis of systemic inflammatory response syndrome after cardiopulmonary bypass in children with congenital heart disease].
Wang X; Li ZX; Wen YP; Chang C
Zhongguo Dang Dai Er Ke Za Zhi; 2018 Jan; 20(1):28-31. PubMed ID: 29335078
[TBL] [Abstract][Full Text] [Related]
20. Expression analysis of immune-regulatory molecules HLA-G, HLA-E and IDO in endometrial cancer.
Ben Yahia H; Boujelbene N; Babay W; Ben Safta I; Dhouioui S; Zemni I; Ali Ayadi M; Charfi L; Ouzari HI; Rebmann V; Rizzo R; Mrad K; Driss M; Zidi I
Hum Immunol; 2020 Jun; 81(6):305-313. PubMed ID: 32273131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
